Diligence memo · auto-generated · as of July 2, 2026

Align Technology Inc

Align Technology Inc has raised $72M over 1 round; too few niche peers to rank its valuation yet.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Align Technology Inc operates in Biotechnology, based in SANTA CLARA.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Align Technology Inc has raised $72M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $72M on 2009-08-16.

Most recent recorded round closed around 2009-08-16.

Valuation (modeled)modeled

Provath models Align Technology Inc at approximately $3.0B (range $224M–$7.8B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Last raise 16.9 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 87% of Biotechnology peers (4293 compared).

Modeled value ranks above 97% of those peers.

Closest niche peers: Helicon Therapeutics Inc, Affymax Inc.

Peoplefiled

16 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.